Cargando…

Preclinical study of safety and immunogenicity of combined rubella and human papillomavirus vaccines: Towards enhancing vaccination uptake rates in developing countries

Rubella vaccine was not part of national immunization programs (NIP) in several countries in the Middle East and North Africa (MENA), South-East Asia (SEA), and South Africa regions until the year 2000. Therefore, immunization coverage of females older than 20 years old in these countries has been t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gohar, Asmaa, Abdeltawab, Nourtan F., Shehata, Nahla, Amin, Magdy A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6586776/ https://www.ncbi.nlm.nih.gov/pubmed/31185296 http://dx.doi.org/10.1016/j.pvr.2019.100172

Ejemplares similares

Development of safe, effective and immunogenic vaccine candidate for diarrheagenic Escherichia coli main pathotypes in a mouse model
por: Gohar, Asmaa, et al.
Publicado: (2016)

Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model
por: AbdelAllah, Nourhan H., et al.
Publicado: (2016)

The impact of Measles-Rubella vaccination on the morbidity and mortality from Congenital Rubella Syndrome in 92 countries
por: Vynnycky, Emilia, et al.
Publicado: (2018)

Sero-Surveillance to Assess Immunity to Rubella and Assessment of Immunogenicity and Safety of a Single dose of Rubella Vaccine in School Girls
por: Sharma, Hitt, et al.
Publicado: (2010)

A Case of Rubella Caused by Rubella Vaccination
por: Kamada, Momoka, et al.
Publicado: (2021)

Rubella Vaccine Uptake among Women of Childbearing Age in Healthcare Settings
por: Ferrari, Cristiana, et al.
Publicado: (2023)

Attitudes toward Rubella and Varicella Vaccination during Preconception Care
por: Foley, Elise, et al.
Publicado: (2021)

Knowledge and Practice of Parents Towards Measles, Mumps and Rubella Vaccination
por: Hussein, Siti Zuhaida, et al.
Publicado: (2022)

2763. Uptake and Safety of Measles-Mumps-Rubella (MMR) Vaccine in Adolescents and Adults in the Vaccine Safety Datalink
por: Hanson, Kayla E, et al.
Publicado: (2019)

The Impact of Recent Rubella Vaccine Introduction in 5 Countries in The African Region
por: Luce, Richard, et al.
Publicado: (2018)

Immunogenicity of measles-rubella vaccine administered under India’s Universal Immunization Programme in the context of measles–rubella elimination goal: A longitudinal study
por: Verma, Santosh Kumar, et al.
Publicado: (2023)

Human papillomavirus vaccination uptake in low-and middle-income countries: a meta-analysis
por: Dorji, Thinley, et al.
Publicado: (2021)

Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis
por: Schenk, Julie, et al.
Publicado: (2021)

Preclinical immunogenicity of an adenovirus-vectored vaccine for herpes zoster
por: Ulaszewska, Marta, et al.
Publicado: (2023)

Pervasive Parental Hesitancy and Resistance towards Measles Rubella Vaccination in Jordan
por: Barakat, Muna, et al.
Publicado: (2023)

Vaccines against human papillomavirus in low and middle income countries: a review of safety, immunogenicity and efficacy
por: Nakalembe, Miriam, et al.
Publicado: (2015)

Rubella IgM epidemiology in the pre-rubella vaccination era in Uganda
por: Bagenda, Fred, et al.
Publicado: (2020)

Two-dose measles–rubella vaccine schedule for measles–rubella elimination
por: John, T. Jacob
Publicado: (2023)

Modeling the impact of rubella vaccination in Vietnam
por: Vynnycky, Emilia, et al.
Publicado: (2016)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Maternal predictors of timeliness & uptake of Measles, Mumps & Rubella vaccine: A birth cohort study
por: Skirrow, H, et al.
Publicado: (2023)

Health economics of rubella: a systematic review to assess the value of rubella vaccination
por: Babigumira, Joseph B, et al.
Publicado: (2013)

Rubella seroprevalence among mothers and incidence of congenital rubella three years after rubella vaccine introduction in Vietnam
por: Toizumi, Michiko, et al.
Publicado: (2021)

Geospatial patterns of human papillomavirus vaccine uptake in Minnesota
por: Nelson, Erik J, et al.
Publicado: (2015)

Safety and immunogenicity of human papillomavirus vaccination in juvenile patients with rheumatic diseases
por: Heijstek, MW, et al.
Publicado: (2011)

Immunogenicity, efficacy, and safety of human papillomavirus vaccine: Data from China
por: Li, Mingzhu, et al.
Publicado: (2023)

The Impact of Rubella Vaccine Introduction on Rubella Infection and Congenital Rubella Syndrome: A Systematic Review of Mathematical Modelling Studies
por: Motaze, Nkengafac Villyen, et al.
Publicado: (2021)

Vaccination in secondary school students expedites rubella control and prevents congenital rubella syndrome
por: He, Hanqing, et al.
Publicado: (2016)

Difficulties in Eliminating Measles and Controlling Rubella and Mumps: A Cross-Sectional Study of a First Measles and Rubella Vaccination and a Second Measles, Mumps, and Rubella Vaccination
por: Wang, Zhifang, et al.
Publicado: (2014)

Epidemiology of acute rubella infection in Zambia during the pre-vaccination period (2005–2016) as a baseline for monitoring rubella epidemiology in the post-rubella vaccine introduction era
por: Mazaba, Mazyanga L., et al.
Publicado: (2020)

Efficacy, Immunogenicity, and Safety of a 9-Valent Human Papillomavirus Vaccine: Subgroup Analysis of Participants From Asian Countries
por: Garland, S M, et al.
Publicado: (2018)

Relationship Between Media Coverage and Measles-Mumps-Rubella (MMR) Vaccination Uptake in Denmark: Retrospective Study
por: Hansen, Niels Dalum, et al.
Publicado: (2019)

Microtitration of Rubella Virus in Monovalent Vaccinal Products
por: Esna-Ashari, F, et al.
Publicado: (2011)

2017 Measles-Rubella Vaccination Campaign in India
por: Shrivastava, Saurabh RamBihariLal, et al.
Publicado: (2018)

Immunogenicity and efficacy of the COVID-19 candidate vector vaccine MVA-SARS-2-S in preclinical vaccination
por: Tscherne, Alina, et al.
Publicado: (2021)

Preclinical Evaluation of the Immunogenicity and Safety of an Inactivated Enterovirus 71 Candidate Vaccine
por: Hwa, Shi-Hsia, et al.
Publicado: (2013)

Preclinical Development of a Fusion Peptide Conjugate as an HIV Vaccine Immunogen
por: Ou, Li, et al.
Publicado: (2020)

Preclinical safety and immunogenicity of Streptococcus pyogenes (Strep A) peptide vaccines
por: Reynolds, Simone, et al.
Publicado: (2021)

Rubella transmission and the risk of congenital rubella syndrome in Liberia: a need to introduce rubella-containing vaccine in the routine immunization program
por: Woyessa, Abyot Bekele, et al.
Publicado: (2019)

2467. Timeliness of Childhood Vaccination With the Combination Measles–Mumps–Rubella–Varicella Vaccine vs. the Separate Measles–Mumps–Rubella and Varicella Vaccines in the United States
por: Wolfson, Lara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_5camh8usnna67jdu9usf8s7poc